ArticleBioprocess and biosystems engineering2025
Solid-state fermentation of pristinamycin by Streptomyces pristinaespiralis NRRL ISP-5338 using D-optimal design.
Article in Bioprocess and biosystems engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pristinamycin (PST), produced by Streptomyces pristinaespiralis NRRL ISP-5338, is a streptogramin antibiotic with remarkably broad-spectrum bactericidal activity. The production of PST from its natural producer remains challenging. In the literature, a few reports examined PST production using submerged liquid fermentation (SLF). However, the literature survey revealed no reports that studied its production using solid-state fermentation (SSF). To our knowledge, this is the first report about the production optimization of PST using SSF. Therefore, in this study, we aimed to optimize various nutritional and environmental factors influencing its production as one-factor-at-a-time (OFAT) or as a multifactorial response surface method (RSM) using SSF. Three factors, including types of solid substrates, composition of the moistening broth, and incubation time, were optimized as OFAT. The OFAT optimal conditions were wheat bran as a solid substrate, IPS5 as a moistening broth, and 9 days as incubation time. These conditions increased PST production from 0.395 to 0.467 mg/g initial dry substrate (IDS). Using RSM, three factors--the initial pH of the moistening broth, the incubation temperature, and the inoculum size (v/w)--were statistically optimized, and the model was statistically significant with a p-value < 0.05. It resulted in a 2.3-fold increase in PST production (0.910 mg/g IDS) compared to the unoptimized SSF conditions (0.395 mg/g IDS) and a 5.35-fold increase from that obtained by the SLF (0.170 mg /mL). In conclusion, the SSF is an efficient and simple method for PST production, and the optimized conditions are highly recommended for scaling up.
Indexed as
Identifiers
40549143What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.